PeptidePrices safety rating
7/10 · Phase III (not yet approved)
CagriSema Prices
12 vendors · 4 with an issuer-verified COA · lowest 10mg from $40.50 · checked
Where to buy CagriSema: 12 vendors compared
| Vendor | Price | Actions |
|---|---|---|
| 3-test panelVerified COAVanguard Laboratory · Tested Sep 8, 2026 | $40.50 | Buy CagriSema from Studz Peptides |
| 6-test panelVerified COAILS Laboratories · Tested Jul 8, 2026 | $62.50 | Buy CagriSema from Hydro Research |
| $89.25 | Buy CagriSema from Coastal Peptides | |
| $92.86 | Buy CagriSema from Peptide Maxxing | |
| $93.10 | Buy CagriSema from Durham Peptides | |
| $108.8010mg packageChecked today | Buy CagriSema from StrikePoint Peptides | |
| 2-test panelVerified COAFreedom Diagnostics · Tested Jan 8, 2026 | $110.0010mg packageChecked today | Buy CagriSema from Pro Research Peptide |
| 6-test panelVerified COABioSyn Systems · Tested Oct 29, 2025 | $119.99 | Buy CagriSema from Cenexa Labs |
| $125.0010mg packageChecked today | Buy CagriSema from Alpha Carbon Labs | |
| $125.56 | Buy CagriSema from Atlas Longevity | |
| $177.58 | Buy CagriSema from Vital Core Research | |
| $229.9915% off, applied by our link·auto10mg packageChecked today | Buy CagriSema from PureBio Labs |
Tracked every day
CagriSema listing prices, tracked daily
The five cheapest in-stock package prices for CagriSema on each collected day, and the vendors that most often held those places.
Five cheapest in-stock package prices per day
Listed package price before coupons, any vial size. This is not the coupon-adjusted lowest 10mg price used to rank the comparison.
- Cheapest$45.00
- 2nd cheapest$108.80
- 3rd cheapest$109.25
- 4th cheapest$110.00
- 5th cheapest$125.00
Vendors most often in the cheapest five
- Alpha Carbon Labs22 days$125.000.0%
- Pro Research Peptide18 days$110.000.0%
- PureBio Labs15 days$229.99last seen Oct 6, 20260.0%
- Hydro Research11 days$125.00last seen Oct 9, 20260.0%
- Peptide Maxxing10 days$109.25+15.0%
- Cenexa Labs7 days$149.99last seen Oct 7, 20260.0%
- Studz Peptides5 days$45.000.0%
- Coastal Peptides4 days$119.00last seen Sep 28, 2026+67.6%
Top 8 of 9 vendors that reached the cheapest five
Current market data
CagriSema Price Report
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for CagriSema is $40.50 from Studz Peptides. The median across vendors is $109.40.
- Lowest 10mg cost
- $40.50Studz Peptides
- Median 10mg cost
- $109.40One normalized offer per vendor
- Lowest package total
- $40.50Studz Peptides · package size may differ
- Public COA coverage
- 100%12 of 12 vendors
What the market shows
PeptidePrices found 13 in-stock listings from 12 vendors, checked through Oct 10, 2026. The lowest 10mg cost is 63% below the vendor median of $109.40; 6 vendors (50%) fall below that median. 12 of 12 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
How this report is calculated
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
What is CagriSema? Research, safety, and status
CagriSema at a glance
Mechanism
Combination of cagrilintide (amylin agonist) and GLP-1S (GLP-1 agonist); dual mechanism targets appetite, gastric emptying, and satiety via complementary central and peripheral pathways; demonstrated greater weight loss than either alone.
Research areas
Obesity (superior weight loss vs. GLP-1S alone, ~25% body weight reduction in trials); type 2 diabetes; metabolic syndrome; next-generation weight management.
Regulatory / research status
FDA approved (for specific indications)
Half-life
GLP-1S ~1 week; Cagrilintide ~7-8 days.
Storage
Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.
Reported side effects
Nausea, vomiting, diarrhea (additive GI effects vs. either alone); constipation. Profile similar to GLP-1 class.
Strong Phase III data; GI side effects similar to GLP-1S; regulatory review ongoing Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Study highlights
- Fixed-ratio combination of cagrilintide (amylin analogue) + GLP-1S (GLP-1 agonist) in a once-weekly subcutaneous injection, dual complementary mechanisms targeting satiety, gastric emptying, and energy expenditure.
- REIMAGINE Phase 2/3 trials demonstrated ~25% mean body weight loss at 68 weeks, with significant improvements in HbA1c, waist circumference, and blood pressure.
- Superior to either component alone, supporting the hypothesis that combinatorial incretin/amylin signaling is more effective than any single-pathway approach.
Selected references
- Coadministered Cagrilintide and GLP-1S 2.4 mg in Adults with Obesity, Phase 3 · New England Journal of Medicine, 2025
- Safety, Pharmacokinetics, and Pharmacodynamics of Cagrilintide with GLP-1S 2.4 mg · The Lancet, 2021
- Structural Features of Cagrilintide Binding to Calcitonin-Family Receptors · Nature Communications, 2025
Related pages